PULMONX CORPORATION (LUNG) Net margin 2018–2025
PULMONX CORPORATION (LUNG) net profit margin by fiscal year — reported net income divided by reported revenue.
-59.7%FY2025 · since FY2018: -92.4% → -59.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -59.7% | +7.6 pp |
| FY2024 | -67.3% | +21.3 pp |
| FY2023 | -88.6% | +21.2 pp |
| FY2022 | -109.8% | -9.3 pp |
| FY2021 | -100.5% | -2.0 pp |
| FY2020 | -98.5% | -35.0 pp |
| FY2019 | -63.5% | +28.9 pp |
| FY2018 | -92.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More LUNG financial trends
LUNG RevenueLUNG Net incomeLUNG Gross profitLUNG Gross marginLUNG Operating incomeLUNG Operating marginLUNG Operating cash flowLUNG Free cash flowLUNG Capital expendituresLUNG Return on equityLUNG Stock buybacksLUNG Dividends paidLUNG Total assetsLUNG Total liabilitiesLUNG Shareholders’ equityLUNG overview →